RNA as an off-target for FDA-approved drugs
Nat Chem
.
2023 Oct;15(10):1329-1331.
doi: 10.1038/s41557-023-01330-x.
Authors
Christopher R Fullenkamp
1
,
John S Schneekloth Jr
2
Affiliations
1
Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.
2
Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA. schneeklothjs@mail.nih.gov.
PMID:
37697037
DOI:
10.1038/s41557-023-01330-x
No abstract available